Brian Kotzin

Brian is a board-certified rheumatologist and internist and is currently senior vice president, clinical development at Nektar Therapeutics, Inc. He previously served as vice president, global and clinical development and head, inflammation therapeutic area at Amgen, directing the global development efforts for Amgen product candidates in inflammation. During his time at Amgen, he also served as vice president of medical sciences, which encompassed early development, biomarker development, and clinical immunology. Brian has won numerous honors, including elected “Master” of the American College of Rheumatology, the Kirkland Scholar Award for Lupus Research, and Chairmanship of the National Institutes of Health Autoimmunity Centers of Excellence. He is an elected member of the American Association of Clinical Investigation and the Association of American Physicians.

Brian completed his medical education at Stanford University and residency in internal medicine at the Beth Israel Hospital at Harvard. He completed his rheumatology fellowship in Division of Rheumatology and Immunology at Stanford University Medical Center.